CVS Group plc Exercise of SAYE Options, PDMR Dealing and TVR (5979S)

TIDMCVSG

RNS Number : 5979S

CVS Group plc

10 March 2023

CVS Group Plc

("CVS" or the "Company")

Exercise of SAYE Options, PDMR Dealing

and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services, announces that on 10 March 2023, options over a total of 1,667 ordinary shares of 0.2 pence each (the "Ordinary Shares") were exercised under the CVS Group 2019 SAYE Plan (2019/2023), at an exercise price of GBP8.63 (the "SAYE Exercise").

The sum of 1,667 Ordinary shares were satisfied from the shares held in the Employee Benefit Trust managed by JTC Group. As a result, no new Ordinary Shares were issued to satisfy the SAYE Exercise.

Ben Jacklin, Chief Operating Officer exercised options over 709 Ordinary Shares in the Company. The balance of the options were exercised by certain other employees and former employees of the Company.

Following his option exercise, Ben Jacklin holds a beneficial interest in 23,093 Ordinary Shares in the Company, representing approximately 0.032 per cent of the total voting rights of the Company, calculated on the same basis.

Following the SAYE Exercise, the Company has a total issued share capital of 71,385,048 Ordinary Shares each carrying one voting right. The Company holds no Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company will be 71,385,048. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                             Ben Jacklin 
     -------------------------------  ---------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  Chief Operating Officer 
     -------------------------------  ---------------------------------- 
 b)   Initial notification             Initial Notification 
       /Amendment 
     -------------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             CVS Group plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800J41XDQ2NX48O05 
     -------------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 
 
 a)   Description of the financial   Ordinary shares of 0.2 pence each 
       instrument, type of 
       instrument                     GB00B2863827 
 
       Identification code 
 b)   Nature of the transaction     Exercise of options under the 2019 
                                     SAYE Plan (1 January 2023 maturity) 
     -----------------------------  ------------------------------------ 
 c)   Price(s) and volume(s) 
                                      Price(s)    Volume 
                                       GBP8.63      709 
     -----------------------------  ------------------------------------ 
 d)   Aggregated information 
 
        *    Aggregated volume 
                                       N/A - single transaction 
 
 
        *    Price 
     -----------------------------  ------------------------------------ 
 e)   Date of the transaction        10 March 2023 
     -----------------------------  ------------------------------------ 
f)    Place of the transaction       Outside a trading venue 
     -----------------------------  ------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHJMMMTMTJBBAJ

(END) Dow Jones Newswires

March 10, 2023 05:37 ET (10:37 GMT)

CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024